See other companies on Welcome to the Jungle
Charco Neurotech
Wearable devices for people with Parkinson's
- 21-100 employees
- Healthcare
- B2C
- Artificial Intelligence
- Science
- MedTech
- Central Cambridge, Cambridge, UK
Jump to section
Company mission
Charco Neurotech is an early stage MedTech start-up that has developed the CUE1, a non-invasive, wearable device which alleviates the symptoms of Parkinson’s. We are a small, rapidly-growing, international team of designers, scientists, engineers and doctors, all linked together by our passion for improving quality of life for people with long-term condition
Our take
Over 10 million people around the world are suffering with stiffness and slowness caused by Parkinson’s Disease. Charco Neurotech have developed CUE1, a focused vibrotactile stimulation device that provides smoother and better coordinated movement for users.
CUE1 is the first of several MedTech products currently in Charco’s pipeline. The device attaches to a patient’s chest and emits vibrations, which are controlled by proprietary algorithms, to provide focused stimulation and cueing that are expected to improve patients’ motor performance and ease freezing.
Looking ahead, Charco is planning to launch a clinical trial to validate the device’s effectiveness at easing Parkinson’s motor symptoms in a larger group of patients. The device’s manufacture and commercialisation will likely follow if this is as much of a success as the attention it has already drawn.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Remote working
Funding (last 2 of 3 rounds)
Nov 2021
$10m
SEED
Mar 2021
$0.7m
SEED
Total funding: $11m
This company has top investors
Leadership
Lucy Jung
(CEO)Former industrial designer at Samsung Design Membership, MSc in Innovation Design Engineer from Imperial College London.
Floyd Pierres
(Chief Medical Officer)NHS Junior Doctor.